Conference on gram-positive bacteria and their infections
Official title: 2024 International Conference on Gram Positive Pathogens
Funded at University of Kansas Medical Center · NIH-10996362 · Data updated 2026-11-12
This conference brings together scientists to share ideas and solutions about infections caused by certain bacteria, like Clostridioides difficile, so they can work together to find better ways to fight these germs and improve treatments for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | August 15, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $7,000 |
| NIH project number | 1R13AI186260-01 |
| Project ID | NIH-10996362 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals affected by infections caused by gram-positive bacteria, including those with antibiotic-associated colitis.
✕Less likely to help
Patients with infections caused by gram-negative bacteria may not receive direct benefits from this research.
What this research studies
The International Conference on Gram-Positive Pathogens (ICGPP) gathers scientists to discuss and share research on gram-positive bacteria, which are responsible for various infections. This event allows researchers at all career stages to exchange ideas and strategies related to antibiotic resistance and the biological functions of these pathogens. Participants will explore topics such as protein secretion, cell wall biosynthesis, and the growing threat of infections like Clostridioides difficile. The conference aims to enhance collaboration and innovation in tackling the challenges posed by these bacteria.
Why it matters
Potential benefit: If successful, this conference could lead to improved understanding and strategies for managing infections caused by gram-positive pathogens.
How similar studies have gone: Previous conferences on similar topics have successfully fostered collaboration and innovation in the field, indicating a positive trend in addressing these health challenges.
Where this research is happening
-
University of Kansas Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Bose, Jeffrey Lee — University of Kansas Medical Center
- Study coordinator: Bose, Jeffrey Lee
Related research
Other NIH-funded projects on the same topics.
-
Motor-Cognitive Training for Older Adults at Risk of Dementia
A Phase II trial tests a combined motor and cognitive training program for older adults at risk of dementia to see if it helps daily function and slows dementia onset.
-
MOVE Peds: Moving Toward Better Outcomes for Pediatric FSHD
A study in kids with a rare muscle disease (FSHD) will test how well certain outcomes reflect change and help guide future clinical trials.
-
How DNA methylation changes in our cells affect gene activity
This project studies how chemical changes to DNA, and the way DNA is packaged, influence how genes turn on or off in vertebrate cells.
-
Dietary oxysterols and metabolic dysfunction in the gut-liver axis
Aims to understand how oxidized cholesterol byproducts in processed foods affect gut and liver health, especially in adults with type 2 diabetes or related conditions.
-
Intermittent fasting and blood sugar in adults with diabetes
A study will look at how two forms of intermittent fasting might improve blood sugar control in adults with type 2 diabetes.
-
Dysfunctional fat tissue and its link to fatty liver and diabetes
Researchers are studying how problems in fat tissue contribute to fatty liver disease and type 2 diabetes in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.